HKSHF yields 1.25% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, HKSHF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HKSHF + JNJ for your $10,000?
The Hongkong and Shanghai Hotels, Limited, an investment holding company, engages in the ownership, development, and management of hotels, and commercial and residential properties in Asia, the United States, and Europe. It operates through three divisions: Hotels, Commercial Properties, and Clubs and Services. The Hotels division is involved in the operation of hotels; and leasing of commercial shopping arcades and office premises located within the hotel buildings. The Commercial Properties division engages in the development, lease, and sale of residential apartments; and lease of retail and office premises, as well as operation of food and beverage outlets in such premises. The Clubs and Services division operates golf courses, as well as The Peak Tram, a tramway; wholesales and retails food and beverage products; and offers laundry, and management and consultancy services for clubs. The company is also involved in the wholesale and retail of merchandise; provision of dry cleaning, and marketing services; lending and borrowing of funds; and operates golf club and resort, and property investment activities. In addition, it offers tourism, leisure, and other services; and operates Peninsula Boutiques. The company was formerly known as The Hongkong Hotel Company, Limited. The Hongkong and Shanghai Hotels, Limited was incorporated in 1866 and is headquartered in Central, Hong Kong.
Full HKSHF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.